Amanda Adler
Professor of Diabetic Medicine and Health Policy
- Director of Diabetes Trials Unit
Recent publications
-
Accurate accounting of caplacizumab cost effectiveness – Authors' reply
Journal article
Hughes M. et al, (2021), The Lancet Haematology, 8
-
Adjusting for Nonadherence or Stopping Treatments in Randomized Clinical Trials.
Journal article
Adler AI. and Latimer NR., (2021), JAMA, 325, 2110 - 2111
-
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Journal article
Adler A. et al, (2021), The Lancet, 397, 1625 - 1636
-
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Journal article
Copland E. et al, (2021), Lancet Oncol, 22, 558 - 570
-
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Journal article
Copland E. et al, (2021), Lancet Oncol, 22, 558 - 570